Text this: Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 _    _      ___     _____      ______   _    _   
| |  | ||   / _ \\  |  __ \\   /_   _// | \  / || 
| |/\| ||  / //\ \\ | |  \ ||   -| ||-  |  \/  || 
|  /\  || |  ___  ||| |__/ ||   _| ||_  | .  . || 
|_// \_|| |_||  |_|||_____//   /_____// |_|\/|_|| 
`-`   `-` `-`   `-`  -----`    `-----`  `-`  `-`